Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
AssigneeVegenics Pty Limited
InventorsKari Alitalo, Markku M. Jeltsch
Life of this patent
Estimating the term…
Abstract
The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.
Claims12
A method of modulating the growth of mammalian endothelial cells or mammalian endothelial precursor cells, comprising contacting the cells with a polypeptide comprising an amino acid sequence that is at least 95% identical to a chimeric vascular endothelial growth factor (VEGF) amino acid sequence selected from the group consisting of SEQ ID NO:
- 241 (construct 11-3) or SEQ ID NO:
- 209 (construct 13-1),
- wherein the polypeptide binds to human VEGFR-1 and human VEGFR-2, and
- wherein the polypeptide further includes one or more amino acid sequences selected from the group consisting of a prepro-VEGF-C signal peptide, a prepro-VEGF-C amino-terminal propeptide, and a prepro-VEGF-C carboxy-terminal pro-peptide.
A method of modulating the growth of mammalian hematopoietic progenitor cells, comprising the step of contacting the cells with a polypeptide in an amount effective to modulate the growth of the cells, wherein the polypeptide comprising an amino acid sequence of the formula:
- XN-V/PHD-XC,
- wherein XN comprises amino acids 1-111 of SEQ ID NO:
- 22 or a fragment thereof;
- wherein V/PHD comprises an amino acid sequence at least 95% identical to the amino acid sequence of SEQ ID NO:
- 241 (construct 11-3) or SEQ ID NO:
- 209 (construct 13-1);
- wherein XC comprises amino acids 217-419 of SEQ ID NO:
- 22 or a fragment thereof;
- wherein XN and XC are each identical to an amino acid sequence in a naturally occurring human VEGF-C precursor protein;
- and
- wherein the polypeptide binds human VEGFR-1 and human VEGFR-2.
A method of modulating the growth of mammalian endothelial cells or mammalian endothelial precursor cells, comprising contacting the cells with a polypeptide comprising an amino acid sequence of the formula:
- XN-V/PHD-XC,
- wherein XN comprises amino acids 1-111 of SEQ ID NO:
- 22 or a fragment thereof;
- wherein V/PHD comprises an amino acid sequence at least 95% identical to an amino acid sequence of the formula:
- NH2-X1-X2-X3-X4-X5-X6-X7-X8-X9-COOH
- wherein X1 is amino acids 3-11 of SEQ ID NO:
- 128;
- wherein X2 is SEQ ID NO:
- 129;
- wherein X3 is SEQ ID NO:
- 130;
- wherein X4 is SEQ ID NO:
- 131;
- wherein X5 is SEQ ID NO:
- 132;
- wherein X6 is SEQ ID NO:
- 142;
- wherein X7 is SEQ ID NO:
- 134;
- wherein X8 is SEQ ID NO:
- 135;
- and wherein X9 is SEQ ID NO:
- 136;
- or
- wherein X1 is amino acids 3-11 of SEQ ID NO:
- 128;
- wherein X2 is SEQ ID NO:
- 129;
- wherein X3 is SEQ ID NO:
- 130;
- wherein X4 is SEQ ID NO:
- 131;
- wherein X5 is SEQ ID NO:
- 141;
- wherein X6 is SEQ ID NO:
- 133;
- wherein X7 is SEQ ID NO:
- 134;
- wherein X8 is SEQ ID NO:
- 135;
- and wherein X9 is SEQ ID NO:
- 136;
- wherein XC comprises amino acids 217-419 of SEQ ID NO:
- 22 or a fragment thereof;
- wherein XN and XC are each identical to an amino acid sequence in a naturally occurring human VEGF-C precursor protein;
- and
- wherein the polypeptide binds to human VEGFR-1 and human VEGFR-2.
Dependencies are inferred from the claim text.